BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Friess H, Büchler M, Auerbach B, Weber A, Malfertheiner P, Hammer K, Madry N, Greiner S, Bosslet K, Beger HG. CA 494--a new tumor marker for the diagnosis of pancreatic cancer. Int J Cancer 1993;53:759-63. [PMID: 8449599 DOI: 10.1002/ijc.2910530509] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Moossa A, Gamagami RA. Diagnosis and Staging of Pancreatic Neoplasms. Surgical Clinics of North America 1995;75:871-90. [DOI: 10.1016/s0039-6109(16)46733-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
2 Hille ET, van Duijn E, Gruis NA, Rosendaal FR, Bergman W, Vandenbroucke JP. Excess Cancer Mortality in Six Dutch Pedigrees with the Familial Atypical Multiple Mole-Melanoma Syndrome from 1830 to 1994. Journal of Investigative Dermatology 1998;110:788-92. [DOI: 10.1046/j.1523-1747.1998.00185.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
3 Eskelinen M, Haglund U. Developments in serologic detection of human pancreatic adenocarcinoma. Scand J Gastroenterol 1999;34:833-44. [PMID: 10522599 DOI: 10.1080/003655299750025273] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
4 Pamies RJ, Crawford DR. Tumor markers. An update. Med Clin North Am 1996;80:185-99. [PMID: 8569297 DOI: 10.1016/s0025-7125(05)70435-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
5 Howard TJ. Pancreatic adenocarcinoma. Current Problems in Cancer 1996;20:281-328. [DOI: 10.1016/s0147-0272(96)80001-8] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
6 Qian L, Li Q, Baryeh K, Qiu W, Li K, Zhang J, Yu Q, Xu D, Liu W, Brand RE, Zhang X, Chen W, Liu G. Biosensors for early diagnosis of pancreatic cancer: a review. Transl Res 2019;213:67-89. [PMID: 31442419 DOI: 10.1016/j.trsl.2019.08.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 14.5] [Reference Citation Analysis]
7 Uno K, Azuma T, Nakajima M, Yasuda K, Hayakumo T, Mukai H, Sakai T, Kawai K. Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma: Cathepsin E in pancreatic juice. Journal of Gastroenterology and Hepatology 2000;15:1333-8. [DOI: 10.1046/j.1440-1746.2000.2351.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
8 Rückert F, Pilarsky C, Grützmann R. Serum tumor markers in pancreatic cancer-recent discoveries. Cancers (Basel) 2010;2:1107-24. [PMID: 24281109 DOI: 10.3390/cancers2021107] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 2.7] [Reference Citation Analysis]
9 Han JS, Nair PP. Flow cytometric identification of cell surface markers on cultured human colonic cell lines using monoclonal antibodies. Cancer 1995;76:195-200. [PMID: 8625091 DOI: 10.1002/1097-0142(19950715)76:2<195::aid-cncr2820760206>3.0.co;2-e] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
10 Sharma C, Eltawil KM, Renfrew PD, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. World J Gastroenterol. 2011;17:867-897. [PMID: 21412497 DOI: 10.3748/wjg.v17.i7.867] [Cited by in CrossRef: 114] [Cited by in F6Publishing: 100] [Article Influence: 11.4] [Reference Citation Analysis]
11 Shin EJ, Canto MI. Pancreatic cancer screening. Gastroenterol Clin North Am. 2012;41:143-157. [PMID: 22341255 DOI: 10.1016/j.gtc.2011.12.001] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
12 Su SB, Qin SY, Chen W, Luo W, Jiang HX. Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis. World J Gastroenterol 2015;21:4323-33. [PMID: 25892884 DOI: 10.3748/wjg.v21.i14.4323] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
13 Audisio RA, Veronesi P, Maisonneuve P, Chiappa A, Andreoni B, Bombardieri E, Geraghty JG. Clinical relevance of serological markers in the detection and follow-up of pancreatic adenocarcinoma. Surg Oncol 1996;5:49-63. [PMID: 8853239 DOI: 10.1016/s0960-7404(96)80001-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
14 Tang Y, Cui Y, Zhang S, Zhang L. The sensitivity and specificity of serum glycan-based biomarkers for cancer detection. Prog Mol Biol Transl Sci 2019;162:121-40. [PMID: 30905445 DOI: 10.1016/bs.pmbts.2019.01.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
15 Gansauge F, Gansauge S, Parker N, Beger MI, Poch B, Link KH, Safi F, Beger HG. CAM 17.1--a new diagnostic marker in pancreatic cancer. Br J Cancer. 1996;74:1997-2002. [PMID: 8980403 DOI: 10.1038/bjc.1996.666] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
16 Haycox, Lombard, Neoptolemos, Walley. Review article: current practice and future perspectives in detection and diagnosis of pancreatic cancer: REVIEW: DETECTION AND DIAGNOSIS OF PANCREATIC CANCER. Alimentary Pharmacology & Therapeutics 1998;12:937-48. [DOI: 10.1046/j.1365-2036.1998.00393.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
17 Wang C, Xu R, Yuan Q, Wang Y, Shen D, Wang X, Gao W, Zhang H, Jiang H. Bioinformatics Method to Analyze the Mechanism of Pancreatic Cancer Disorder. Journal of Computational Biology 2013;20:444-52. [DOI: 10.1089/cmb.2012.0281] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
18 Uno K, Azuma T, Nakajima M, Yasuda K, Hayakumo T, Mukai H, Sakai T, Kawai K. Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma. J Gastroenterol Hepatol 2000;15:1333-8. [DOI: 10.1046/j.1440-1746.2000.02351.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
19 Minghini A, Weireter LJ, Perry RR. Specificity of elevated CA 19-9 levels in chronic pancreatitis. Surgery. 1998;124:103-105. [PMID: 9663259 DOI: 10.1016/s0039-6060(98)70082-0] [Cited by in Crossref: 12] [Article Influence: 0.5] [Reference Citation Analysis]
20 Azuma T, Hirai M, Ito S, Yamamoto K, Taggart RT, Matsuba T, Yasukawa K, Uno K, Hayakumo T, Nakajima M. Expression of cathepsin E in pancreas: A possible tumor marker for pancreas, a preliminary report. Int J Cancer 1996;67:492-7. [DOI: 10.1002/(sici)1097-0215(19960807)67:4<492::aid-ijc5>3.0.co;2-n] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
21 Abdallah AA, Krige JE, Bornman PC. Biliary tract obstruction in chronic pancreatitis. HPB (Oxford). 2007;9:421-428. [PMID: 18345288 DOI: 10.1080/13651820701774883] [Cited by in Crossref: 82] [Cited by in F6Publishing: 48] [Article Influence: 7.5] [Reference Citation Analysis]